Showing results (1-10 of 542) with videos related to
Sort By:
Pageof 55
Physiological Reviews|October 21, 2010
Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking taleBeth A Rose, Thomas Force, Yibin WangDrug Discovery Today|July 12, 2008
Cardiotoxicity of the new cancer therapeutics--mechanisms of, and approaches to, the problemThomas Force, Risto KerkeläCurrent Heart Failure Reports|May 11, 2006
Recent insights into cardiac hypertrophy and left ventricular remodelingRisto Kerkela, Thomas ForceCirculation Research|January 9, 2010
Molecular mechanisms of cardiovascular toxicity of targeted cancer therapeuticsHui Cheng, Thomas ForceProgress in Cardiovascular Diseases|August 24, 2010
Why do kinase inhibitors cause cardiotoxicity and what can be done about it?Hui Cheng, Thomas ForceThe Journal of Biological Chemistry|December 10, 2008
Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular developmentThomas Force, James R WoodgettNature Reviews. Drug Discovery|February 2, 2011
Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomesThomas Force, Kyle L KolajaThe Journal of Clinical Investigation|March 15, 2005
Protein kinase cascades in the regulation of cardiac hypertrophyGerald W Dorn, Thomas ForceTrends in Cardiovascular Medicine|April 10, 2007
Glycogen synthase kinase-3beta -- actively inhibiting hypertrophyRisto Kerkelä, Kathleen Woulfe, Thomas ForceCirculation|September 19, 2007
Mitogen-activated protein kinases in heart development and diseasesYibin WangPageof 55